National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 4 of 4 Research Studies DisplayedChou R, Dana T, Blazina I
Screening for dyslipidemia in younger adults: a systematic review for the U.S. Preventive Services Task Force.
This study's purpose was to update the 2008 U.S. Preventive Services Task Force review on dyslipidemia screening in younger adults. However, no study met the inclusion criteria. As direct evidence remains unavailable, estimating the potential effects of screening for dyslipidemia in younger adults requires extrapolation from studies performed in older adults.
Citation: Chou R, Dana T, Blazina I .
Screening for dyslipidemia in younger adults: a systematic review for the U.S. Preventive Services Task Force.
Ann Intern Med 2016 Oct 18;165(8):560-64. doi: 10.7326/m16-0946.
.
.
Keywords: U.S. Preventive Services Task Force (USPSTF), Screening, Young Adults, Heart Disease and Health, Prevention
Karmali KN, Lee JY, Brown T
Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers.
The authors aimed to identify factors associated with a cholesterol treatment discussion and statin prescribing in a high-risk population. They found that single risk factor management strongly influences cholesterol treatment discussions and statin prescribing patterns, and they recommended interventions that promote risk-based statin use.
AHRQ-funded; HS021141.
Citation: Karmali KN, Lee JY, Brown T .
Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers.
Prev Med 2016 Jul;88:176-81. doi: 10.1016/j.ypmed.2016.04.011.
.
.
Keywords: Cardiovascular Conditions, Heart Disease and Health, Community-Based Practice, Medication, Prevention
Chrischilles EA, Schneider KM, Schroeder MC
Association between preadmission functional status and use and effectiveness of secondary prevention medications in elderly survivors of acute myocardial infarction.
The researchers sought to determine whether function-related indicators, derived from preadmission claims data, help explain the frequent practice of forgoing secondary prevention medications observed in Medicare. They found that greater impairment in preadmission functional status, using a measure derived from claims data, was associated with less use of secondary prevention medications after acute myocardial infarction.
AHRQ-funded; HS018381; HS019440.
Citation: Chrischilles EA, Schneider KM, Schroeder MC .
Association between preadmission functional status and use and effectiveness of secondary prevention medications in elderly survivors of acute myocardial infarction.
J Am Geriatr Soc 2016 Mar;64(3):526-35. doi: 10.1111/jgs.13953.
.
.
Keywords: Elderly, Prevention, Medication, Heart Disease and Health
Zeitler EP, Hellkamp AS, Schulte PJ
Comparative effectiveness of implantable cardioverter defibrillators for primary prevention in women.
The researchers examined clinical practice data to compare survival rates among women with heart failure with or without a primary prevention implantable cardioverter defibrillator (ICD). Theyn found that among patients with heart failure with reduced left ventricular ejection fraction, a primary prevention ICD was associated with a significant survival advantage among women and among men.
AHRQ-funded; HS021092.
Citation: Zeitler EP, Hellkamp AS, Schulte PJ .
Comparative effectiveness of implantable cardioverter defibrillators for primary prevention in women.
Circ Heart Fail 2016 Jan;9(1):e002630. doi: 10.1161/circheartfailure.115.002630.
.
.
Keywords: Medical Devices, Comparative Effectiveness, Prevention, Heart Disease and Health, Mortality